Concepedia

Brian Elenbaas

BE

Statistics

Publications

22

Citations

4.7K

H-Index

20

Active since

1992

Affiliations

Princeton University(Current)

Merck KGaA, Darmstadt (Germany)

Ono Pharmaceutical (United States)

Harvard University

Whitehead Institute for Biomedical Research

Brian Elenbaas is an author at Princeton University specializing in molecular biology, life sciences, and molecular oncology.

ORCID

Publications per year

1992–2023

22

Publications

22

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells

Brian Elenbaas, Lisa Spirio, F. Koerner et al. · Genes & Development · 2001 · 871 citations · Full text

, , +17

Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

Jiayuh Lin, Jiandong Chen, Brian Elenbaas et al. · Genes & Development · 1994 · 652 citations · Full text

, , +13

Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation

William C. Hahn, Scott Dessain, Mary W. Brooks et al. · Molecular and Cellular Biology · 2002 · 623 citations · Full text

, , +17

Essential function of <i>Wnt-4</i> in mammary gland development downstream of progesterone signaling

Cathrin Brisken, Anna Heineman, Tony E. Chavarria et al. · Genes & Development · 2000 · 485 citations · Full text

, , +17

p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches

Suman Lee, Brian Elenbaas, Arnold J. Levine et al. · Cell · 1995 · 403 citations · Full text

, , +16

1–5 of 22